FunGen-AD grantee Peter St George-Hyslop was part of a collaboration among researchers from the University of Sydney, University of Cambridge, Harvard University, and Columbia University that developed new optical methods to observe development of pathological protein aggregates in cells.
Read moreNews
Proteomic analysis could be used to distinguish sporadic and genetic Alzheimer’s disease
FunGen-AD investigator Carlos Cruchaga and a team of researchers at Washington University School of Medicine in St. Louis analyzed proteins in brain tissue, cerebrospinal fluid (CSF), and plasma samples from patients with sporadic Alzheimer’s Disease (AD) or autosomal dominant AD, TREM2 variant carriers, and healthy individuals.
Read more